ISPC stock has given up its prior gain. iSpecimen shares were trading higher after the company announced it completed an international cancer research project.

Benzinga Newsdesk www.benzinga.com Positive 90.6%

Neg 0% Neu 0% Pos 90.6%

Comments

No comments yet. Be the first!